Non-prescription Drugs and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Non-prescription Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-prescription Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-prescription Drugs Overall Market Size
2.1 Global Non-prescription Drugs Market Size: 2023 VS 2030
2.2 Global Non-prescription Drugs Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Non-prescription Drugs Players in Global Market
3.2 Top Global Non-prescription Drugs Companies Ranked by Revenue
3.3 Global Non-prescription Drugs Revenue by Companies
3.4 Top 3 and Top 5 Non-prescription Drugs Companies in Global Market, by Revenue in 2023
3.5 Global Companies Non-prescription Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Non-prescription Drugs Players in Global Market
3.6.1 List of Global Tier 1 Non-prescription Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Non-prescription Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Non-prescription Drugs Market Size Markets, 2023 & 2030
4.1.2 Brand Drugs
4.1.3 Generic Drug
4.2 By Type - Global Non-prescription Drugs Revenue & Forecasts
4.2.1 By Type - Global Non-prescription Drugs Revenue, 2019-2024
4.2.2 By Type - Global Non-prescription Drugs Revenue, 2025-2030
4.2.3 By Type - Global Non-prescription Drugs Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Non-prescription Drugs Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application - Global Non-prescription Drugs Revenue & Forecasts
5.2.1 By Application - Global Non-prescription Drugs Revenue, 2019-2024
5.2.2 By Application - Global Non-prescription Drugs Revenue, 2025-2030
5.2.3 By Application - Global Non-prescription Drugs Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Non-prescription Drugs Market Size, 2023 & 2030
6.2 By Region - Global Non-prescription Drugs Revenue & Forecasts
6.2.1 By Region - Global Non-prescription Drugs Revenue, 2019-2024
6.2.2 By Region - Global Non-prescription Drugs Revenue, 2025-2030
6.2.3 By Region - Global Non-prescription Drugs Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Non-prescription Drugs Revenue, 2019-2030
6.3.2 US Non-prescription Drugs Market Size, 2019-2030
6.3.3 Canada Non-prescription Drugs Market Size, 2019-2030
6.3.4 Mexico Non-prescription Drugs Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Non-prescription Drugs Revenue, 2019-2030
6.4.2 Germany Non-prescription Drugs Market Size, 2019-2030
6.4.3 France Non-prescription Drugs Market Size, 2019-2030
6.4.4 U.K. Non-prescription Drugs Market Size, 2019-2030
6.4.5 Italy Non-prescription Drugs Market Size, 2019-2030
6.4.6 Russia Non-prescription Drugs Market Size, 2019-2030
6.4.7 Nordic Countries Non-prescription Drugs Market Size, 2019-2030
6.4.8 Benelux Non-prescription Drugs Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Non-prescription Drugs Revenue, 2019-2030
6.5.2 China Non-prescription Drugs Market Size, 2019-2030
6.5.3 Japan Non-prescription Drugs Market Size, 2019-2030
6.5.4 South Korea Non-prescription Drugs Market Size, 2019-2030
6.5.5 Southeast Asia Non-prescription Drugs Market Size, 2019-2030
6.5.6 India Non-prescription Drugs Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Non-prescription Drugs Revenue, 2019-2030
6.6.2 Brazil Non-prescription Drugs Market Size, 2019-2030
6.6.3 Argentina Non-prescription Drugs Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Non-prescription Drugs Revenue, 2019-2030
6.7.2 Turkey Non-prescription Drugs Market Size, 2019-2030
6.7.3 Israel Non-prescription Drugs Market Size, 2019-2030
6.7.4 Saudi Arabia Non-prescription Drugs Market Size, 2019-2030
6.7.5 UAE Non-prescription Drugs Market Size, 2019-2030
7 Non-prescription Drugs Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Non-prescription Drugs Major Product Offerings
7.1.4 Pfizer Non-prescription Drugs Revenue in Global Market (2019-2024)
7.1.5 Pfizer Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Non-prescription Drugs Major Product Offerings
7.2.4 Roche Non-prescription Drugs Revenue in Global Market (2019-2024)
7.2.5 Roche Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Non-prescription Drugs Major Product Offerings
7.3.4 Sanofi Non-prescription Drugs Revenue in Global Market (2019-2024)
7.3.5 Sanofi Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Non-prescription Drugs Major Product Offerings
7.4.4 Johnson & Johnson Non-prescription Drugs Revenue in Global Market (2019-2024)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Merck & Co. (MSD)
7.5.1 Merck & Co. (MSD) Company Summary
7.5.2 Merck & Co. (MSD) Business Overview
7.5.3 Merck & Co. (MSD) Non-prescription Drugs Major Product Offerings
7.5.4 Merck & Co. (MSD) Non-prescription Drugs Revenue in Global Market (2019-2024)
7.5.5 Merck & Co. (MSD) Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Non-prescription Drugs Major Product Offerings
7.6.4 Novartis Non-prescription Drugs Revenue in Global Market (2019-2024)
7.6.5 Novartis Key News & Latest Developments
7.7 AbbVie
7.7.1 AbbVie Company Summary
7.7.2 AbbVie Business Overview
7.7.3 AbbVie Non-prescription Drugs Major Product Offerings
7.7.4 AbbVie Non-prescription Drugs Revenue in Global Market (2019-2024)
7.7.5 AbbVie Key News & Latest Developments
7.8 Gilead Sciences
7.8.1 Gilead Sciences Company Summary
7.8.2 Gilead Sciences Business Overview
7.8.3 Gilead Sciences Non-prescription Drugs Major Product Offerings
7.8.4 Gilead Sciences Non-prescription Drugs Revenue in Global Market (2019-2024)
7.8.5 Gilead Sciences Key News & Latest Developments
7.9 GlaxoSmithKline (GSK)
7.9.1 GlaxoSmithKline (GSK) Company Summary
7.9.2 GlaxoSmithKline (GSK) Business Overview
7.9.3 GlaxoSmithKline (GSK) Non-prescription Drugs Major Product Offerings
7.9.4 GlaxoSmithKline (GSK) Non-prescription Drugs Revenue in Global Market (2019-2024)
7.9.5 GlaxoSmithKline (GSK) Key News & Latest Developments
7.10 Amgen
7.10.1 Amgen Company Summary
7.10.2 Amgen Business Overview
7.10.3 Amgen Non-prescription Drugs Major Product Offerings
7.10.4 Amgen Non-prescription Drugs Revenue in Global Market (2019-2024)
7.10.5 Amgen Key News & Latest Developments
7.11 AstraZeneca
7.11.1 AstraZeneca Company Summary
7.11.2 AstraZeneca Business Overview
7.11.3 AstraZeneca Non-prescription Drugs Major Product Offerings
7.11.4 AstraZeneca Non-prescription Drugs Revenue in Global Market (2019-2024)
7.11.5 AstraZeneca Key News & Latest Developments
7.12 Bristol-Myers Squibb
7.12.1 Bristol-Myers Squibb Company Summary
7.12.2 Bristol-Myers Squibb Business Overview
7.12.3 Bristol-Myers Squibb Non-prescription Drugs Major Product Offerings
7.12.4 Bristol-Myers Squibb Non-prescription Drugs Revenue in Global Market (2019-2024)
7.12.5 Bristol-Myers Squibb Key News & Latest Developments
7.13 Eli Lilly
7.13.1 Eli Lilly Company Summary
7.13.2 Eli Lilly Business Overview
7.13.3 Eli Lilly Non-prescription Drugs Major Product Offerings
7.13.4 Eli Lilly Non-prescription Drugs Revenue in Global Market (2019-2024)
7.13.5 Eli Lilly Key News & Latest Developments
7.14 Teva
7.14.1 Teva Company Summary
7.14.2 Teva Business Overview
7.14.3 Teva Non-prescription Drugs Major Product Offerings
7.14.4 Teva Non-prescription Drugs Revenue in Global Market (2019-2024)
7.14.5 Teva Key News & Latest Developments
7.15 Bayer
7.15.1 Bayer Company Summary
7.15.2 Bayer Business Overview
7.15.3 Bayer Non-prescription Drugs Major Product Offerings
7.15.4 Bayer Non-prescription Drugs Revenue in Global Market (2019-2024)
7.15.5 Bayer Key News & Latest Developments
7.16 Novo Nordisk
7.16.1 Novo Nordisk Company Summary
7.16.2 Novo Nordisk Business Overview
7.16.3 Novo Nordisk Non-prescription Drugs Major Product Offerings
7.16.4 Novo Nordisk Non-prescription Drugs Revenue in Global Market (2019-2024)
7.16.5 Novo Nordisk Key News & Latest Developments
7.17 AbbVie
7.17.1 AbbVie Company Summary
7.17.2 AbbVie Business Overview
7.17.3 AbbVie Non-prescription Drugs Major Product Offerings
7.17.4 AbbVie Non-prescription Drugs Revenue in Global Market (2019-2024)
7.17.5 AbbVie Key News & Latest Developments
7.18 Takeda
7.18.1 Takeda Company Summary
7.18.2 Takeda Business Overview
7.18.3 Takeda Non-prescription Drugs Major Product Offerings
7.18.4 Takeda Non-prescription Drugs Revenue in Global Market (2019-2024)
7.18.5 Takeda Key News & Latest Developments
7.19 Boehringer Ingelheim
7.19.1 Boehringer Ingelheim Company Summary
7.19.2 Boehringer Ingelheim Business Overview
7.19.3 Boehringer Ingelheim Non-prescription Drugs Major Product Offerings
7.19.4 Boehringer Ingelheim Non-prescription Drugs Revenue in Global Market (2019-2024)
7.19.5 Boehringer Ingelheim Key News & Latest Developments
7.20 Takeda
7.20.1 Takeda Company Summary
7.20.2 Takeda Business Overview
7.20.3 Takeda Non-prescription Drugs Major Product Offerings
7.20.4 Takeda Non-prescription Drugs Revenue in Global Market (2019-2024)
7.20.5 Takeda Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Non-prescription Drugs Market Opportunities & Trends in Global Market
Table 2. Non-prescription Drugs Market Drivers in Global Market
Table 3. Non-prescription Drugs Market Restraints in Global Market
Table 4. Key Players of Non-prescription Drugs in Global Market
Table 5. Top Non-prescription Drugs Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Non-prescription Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Non-prescription Drugs Revenue Share by Companies, 2019-2024
Table 8. Global Companies Non-prescription Drugs Product Type
Table 9. List of Global Tier 1 Non-prescription Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-prescription Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Non-prescription Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Non-prescription Drugs Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Non-prescription Drugs Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Non-prescription Drugs Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Non-prescription Drugs Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Non-prescription Drugs Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Non-prescription Drugs Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Non-prescription Drugs Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Non-prescription Drugs Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Non-prescription Drugs Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Non-prescription Drugs Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Non-prescription Drugs Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Non-prescription Drugs Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Non-prescription Drugs Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Non-prescription Drugs Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Non-prescription Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Non-prescription Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Non-prescription Drugs Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Non-prescription Drugs Revenue, (US$, Mn), 2025-2030
Table 30. Pfizer Company Summary
Table 31. Pfizer Non-prescription Drugs Product Offerings
Table 32. Pfizer Non-prescription Drugs Revenue (US$, Mn) & (2019-2024)
Table 33. Pfizer Key News & Latest Developments
Table 34. Roche Company Summary
Table 35. Roche Non-prescription Drugs Product Offerings
Table 36. Roche Non-prescription Drugs Revenue (US$, Mn) & (2019-2024)
Table 37. Roche Key News & Latest Developments
Table 38. Sanofi Company Summary
Table 39. Sanofi Non-prescription Drugs Product Offerings
Table 40. Sanofi Non-prescription Drugs Revenue (US$, Mn) & (2019-2024)
Table 41. Sanofi Key News & Latest Developments
Table 42. Johnson & Johnson Company Summary
Table 43. Johnson & Johnson Non-prescription Drugs Product Offerings
Table 44. Johnson & Johnson Non-prescription Drugs Revenue (US$, Mn) & (2019-2024)
Table 45. Johnson & Johnson Key News & Latest Developments
Table 46. Merck & Co. (MSD) Company Summary
Table 47. Merck & Co. (MSD) Non-prescription Drugs Product Offerings
Table 48. Merck & Co. (MSD) Non-prescription Drugs Revenue (US$, Mn) & (2019-2024)
Table 49. Merck & Co. (MSD) Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis Non-prescription Drugs Product Offerings
Table 52. Novartis Non-prescription Drugs Revenue (US$, Mn) & (2019-2024)
Table 53. Novartis Key News & Latest Developments
Table 54. AbbVie Company Summary
Table 55. AbbVie Non-prescription Drugs Product Offerings
Table 56. AbbVie Non-prescription Drugs Revenue (US$, Mn) & (2019-2024)
Table 57. AbbVie Key News & Latest Developments
Table 58. Gilead Sciences Company Summary
Table 59. Gilead Sciences Non-prescription Drugs Product Offerings
Table 60. Gilead Sciences Non-prescription Drugs Revenue (US$, Mn) & (2019-2024)
Table 61. Gilead Sciences Key News & Latest Developments
Table 62. GlaxoSmithKline (GSK) Company Summary
Table 63. GlaxoSmithKline (GSK) Non-prescription Drugs Product Offerings
Table 64. GlaxoSmithKline (GSK) Non-prescription Drugs Revenue (US$, Mn) & (2019-2024)
Table 65. GlaxoSmithKline (GSK) Key News & Latest Developments
Table 66. Amgen Company Summary
Table 67. Amgen Non-prescription Drugs Product Offerings
Table 68. Amgen Non-prescription Drugs Revenue (US$, Mn) & (2019-2024)
Table 69. Amgen Key News & Latest Developments
Table 70. AstraZeneca Company Summary
Table 71. AstraZeneca Non-prescription Drugs Product Offerings
Table 72. AstraZeneca Non-prescription Drugs Revenue (US$, Mn) & (2019-2024)
Table 73. AstraZeneca Key News & Latest Developments
Table 74. Bristol-Myers Squibb Company Summary
Table 75. Bristol-Myers Squibb Non-prescription Drugs Product Offerings
Table 76. Bristol-Myers Squibb Non-prescription Drugs Revenue (US$, Mn) & (2019-2024)
Table 77. Bristol-Myers Squibb Key News & Latest Developments
Table 78. Eli Lilly Company Summary
Table 79. Eli Lilly Non-prescription Drugs Product Offerings
Table 80. Eli Lilly Non-prescription Drugs Revenue (US$, Mn) & (2019-2024)
Table 81. Eli Lilly Key News & Latest Developments
Table 82. Teva Company Summary
Table 83. Teva Non-prescription Drugs Product Offerings
Table 84. Teva Non-prescription Drugs Revenue (US$, Mn) & (2019-2024)
Table 85. Teva Key News & Latest Developments
Table 86. Bayer Company Summary
Table 87. Bayer Non-prescription Drugs Product Offerings
Table 88. Bayer Non-prescription Drugs Revenue (US$, Mn) & (2019-2024)
Table 89. Bayer Key News & Latest Developments
Table 90. Novo Nordisk Company Summary
Table 91. Novo Nordisk Non-prescription Drugs Product Offerings
Table 92. Novo Nordisk Non-prescription Drugs Revenue (US$, Mn) & (2019-2024)
Table 93. Novo Nordisk Key News & Latest Developments
Table 94. AbbVie Company Summary
Table 95. AbbVie Non-prescription Drugs Product Offerings
Table 96. AbbVie Non-prescription Drugs Revenue (US$, Mn) & (2019-2024)
Table 97. AbbVie Key News & Latest Developments
Table 98. Takeda Company Summary
Table 99. Takeda Non-prescription Drugs Product Offerings
Table 100. Takeda Non-prescription Drugs Revenue (US$, Mn) & (2019-2024)
Table 101. Takeda Key News & Latest Developments
Table 102. Boehringer Ingelheim Company Summary
Table 103. Boehringer Ingelheim Non-prescription Drugs Product Offerings
Table 104. Boehringer Ingelheim Non-prescription Drugs Revenue (US$, Mn) & (2019-2024)
Table 105. Boehringer Ingelheim Key News & Latest Developments
Table 106. Takeda Company Summary
Table 107. Takeda Non-prescription Drugs Product Offerings
Table 108. Takeda Non-prescription Drugs Revenue (US$, Mn) & (2019-2024)
Table 109. Takeda Key News & Latest Developments
List of Figures
Figure 1. Non-prescription Drugs Segment by Type in 2023
Figure 2. Non-prescription Drugs Segment by Application in 2023
Figure 3. Global Non-prescription Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Non-prescription Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Non-prescription Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Non-prescription Drugs Revenue in 2023
Figure 8. By Type - Global Non-prescription Drugs Revenue Market Share, 2019-2030
Figure 9. By Application - Global Non-prescription Drugs Revenue Market Share, 2019-2030
Figure 10. By Type - Global Non-prescription Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Non-prescription Drugs Revenue Market Share, 2019-2030
Figure 12. By Application - Global Non-prescription Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Non-prescription Drugs Revenue Market Share, 2019-2030
Figure 14. By Region - Global Non-prescription Drugs Revenue Market Share, 2019-2030
Figure 15. By Country - North America Non-prescription Drugs Revenue Market Share, 2019-2030
Figure 16. US Non-prescription Drugs Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Non-prescription Drugs Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Non-prescription Drugs Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Non-prescription Drugs Revenue Market Share, 2019-2030
Figure 20. Germany Non-prescription Drugs Revenue, (US$, Mn), 2019-2030
Figure 21. France Non-prescription Drugs Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Non-prescription Drugs Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Non-prescription Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Non-prescription Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Non-prescription Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Non-prescription Drugs Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Non-prescription Drugs Revenue Market Share, 2019-2030
Figure 28. China Non-prescription Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Non-prescription Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Non-prescription Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Non-prescription Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. India Non-prescription Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Non-prescription Drugs Revenue Market Share, 2019-2030
Figure 34. Brazil Non-prescription Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Non-prescription Drugs Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Non-prescription Drugs Revenue Market Share, 2019-2030
Figure 37. Turkey Non-prescription Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Non-prescription Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Non-prescription Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Non-prescription Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. Pfizer Non-prescription Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Roche Non-prescription Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Sanofi Non-prescription Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Johnson & Johnson Non-prescription Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Merck & Co. (MSD) Non-prescription Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Novartis Non-prescription Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. AbbVie Non-prescription Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Gilead Sciences Non-prescription Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. GlaxoSmithKline (GSK) Non-prescription Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Amgen Non-prescription Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. AstraZeneca Non-prescription Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Bristol-Myers Squibb Non-prescription Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Eli Lilly Non-prescription Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Teva Non-prescription Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 55. Bayer Non-prescription Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 56. Novo Nordisk Non-prescription Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 57. AbbVie Non-prescription Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 58. Takeda Non-prescription Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 59. Boehringer Ingelheim Non-prescription Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 60. Takeda Non-prescription Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Industry Market Size
